AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3069760 — intervention group
Group type: EXPERIMENTAL
Intervention: sulconazole nitrate 1% cream applied twice daily for 14 days
Number of subjects: 80
Study 3069760 — intervention group
Group type: COMPARATOR
Intervention: miconazole nitrate 2% cream applied twice daily for 14 days
Number of subjects: 80
Study 29053851 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram 20 mg/d
Number of subjects: 40
Study 29053851 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 28622034 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention (bi-directional text messaging via SMS, WhatsApp, and Facebook) for 12 weeks
Number of subjects: 40
Study 28622034 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention (bi-directional text messaging)
Number of subjects: 40
Study 25756419 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted temperature management at 33°C
Number of subjects: 169
Study 25756419 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted temperature management at 36°C
Number of subjects: 169
Study 25756419 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin levels
Number of subjects: 169
Study 25756419 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin‐6 levels
Number of subjects: 169
Study 23187936 — intervention group
Group type: EXPERIMENTAL
Intervention: MVC 150 mg once daily
Number of subjects: 121
Study 23187936 — intervention group
Group type: COMPARATOR
Intervention: TDF/FTC 300/200 mg once daily + ATV/r 300/100 mg once daily
Number of subjects: 121
Study 22328095 — intervention group
Group type: EXPERIMENTAL
Intervention: Janthinobacterium lividum treatment
Number of subjects: 0
Study 19506932 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatty Fish (FF) diet (4.3 portions of fish per week)
Number of subjects: 27
Study 19506932 — intervention group
Group type: EXPERIMENTAL
Intervention: Lean Fish (LF) diet (4.7 portions of fish per week)
Number of subjects: 27
Study 19506932 — intervention group
Group type: COMPARATOR
Intervention: Control diet (0.6 portions of fish per week)
Number of subjects: 27
Study 16284083 — intervention group
Group type: EXPERIMENTAL
Intervention: 17beta-estradiol supplementation (ES; 2 mg/day)
Number of subjects: 11
Study 16284083 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL; glucose polymer)
Number of subjects: 11
Study 15331898 — intervention group
Group type: EXPERIMENTAL
Intervention: TURP
Number of subjects: 98
Study 15331898 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:YAG laser treatment (contact and hybrid)
Number of subjects: 98
Study 15331898 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 98
Study 10647524 — intervention group
Group type: EXPERIMENTAL
Intervention: New modified configuration
Number of subjects: 36
Study 10647524 — intervention group
Group type: COMPARATOR
Intervention: Original Ma-Griffith configuration
Number of subjects: 36
Study 9497875 — intervention group
Group type: EXPERIMENTAL
Intervention: IGF‐I infusion (43.7 pmol/kg/min or 20 micrograms/kg/h)
Number of subjects: 6
Study 9497875 — intervention group
Group type: COMPARATOR
Intervention: Insulin infusion (3.4 pmol/kg/min or 0.5 mU/kg/min)
Number of subjects: 6
Study 9497875 — intervention group
Group type: COMPARATOR
Intervention: Insulin infusion
Number of subjects: 6
Study 9497875 — intervention group
Group type: EXPERIMENTAL
Intervention: IGF‐I infusion
Number of subjects: 6
Study 9497875 — intervention group
Group type: EXPERIMENTAL
Intervention: IGF‐I and insulin infusions
Number of subjects: 6
Study 8298916 — intervention group
Group type: EXPERIMENTAL
Intervention: Patch angioplasty
Number of subjects: 213
Study 8298916 — intervention group
Group type: COMPARATOR
Intervention: No patch angioplasty (Control)
Number of subjects: 213
Study 3674248 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Care Program (foster home care)
Number of subjects: 112
Study 3674248 — intervention group
Group type: COMPARATOR
Intervention: Nursing home care
Number of subjects: 112
Study 29081326 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) exposure therapy, approximately 1 hour
Number of subjects: 36
Study 29081326 — intervention group
Group type: COMPARATOR
Intervention: Progressive Muscle Relaxation (PMR) and psychoeducation, approximately 30 minutes of PMR and 15 minutes of psychoeducation
Number of subjects: 36
Study 29081326 — intervention group
Group type: EXPERIMENTAL
Intervention: Both VR and PMR groups
Number of subjects: 36
Study 26635305 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher level of amino acids (1.2 g/kg)
Number of subjects: 119
Study 26635305 — intervention group
Group type: COMPARATOR
Intervention: Standard amino acid intake (0.8 g/kg)
Number of subjects: 119
Study 25465451 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral discussion and written handout outlining the risks of otoplasty
Number of subjects: 50
Study 25465451 — intervention group
Group type: COMPARATOR
Intervention: Traditional oral dialog of the surgical risks
Number of subjects: 50
Study 23419912 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial nerve mobilisation
Number of subjects: 60
Study 23419912 — intervention group
Group type: COMPARATOR
Intervention: Non‐therapeutic dose of intermittent ultrasound
Number of subjects: 60
Study 20610230 — intervention group
Group type: EXPERIMENTAL
Intervention: BB(OFF)
Number of subjects: 17
Study 20610230 — intervention group
Group type: COMPARATOR
Intervention: BB(ON)
Number of subjects: 17
Study 19002337 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-fractionated aminolaevulinic acid photodynamic therapy (PDT)
Number of subjects: 32
Study 19002337 — intervention group
Group type: COMPARATOR
Intervention: Control biopsies
Number of subjects: 32
Study 19002337 — intervention group
Group type: EXPERIMENTAL
Intervention: Ki-67 staining
Number of subjects: 32
Study 21592741 — intervention group
Group type: EXPERIMENTAL
Intervention: risperidone
Number of subjects: 24
Study 21592741 — intervention group
Group type: EXPERIMENTAL
Intervention: divalproex
Number of subjects: 24
Study 21592741 — intervention group
Group type: COMPARATOR
Intervention: healthy controls
Number of subjects: 24
Study 16198776 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous-dose terbinafine (250 mg daily for 3 months)
Number of subjects: 306
Study 16198776 — intervention group
Group type: COMPARATOR
Intervention: Pulse-dose terbinafine (500 mg daily for 1 week per month for 3 months)
Number of subjects: 306
Study 11887024 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential amino acids (group B)
Number of subjects: 77
Study 11887024 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acids and vitamins (group C)
Number of subjects: 77
Study 11887024 — intervention group
Group type: COMPARATOR
Intervention: Calcium phosphate (control group D)
Number of subjects: 77
Study 9817939 — intervention group
Group type: EXPERIMENTAL
Intervention: High IL-1beta cytokine production (>/=75th percentile)
Number of subjects: 50
Study 9817939 — intervention group
Group type: COMPARATOR
Intervention: Low IL-1beta cytokine production (<75th percentile)
Number of subjects: 50
Study 9817939 — intervention group
Group type: EXPERIMENTAL
Intervention: High IL-6 cytokine production (>/=75th percentile)
Number of subjects: 50
Study 9817939 — intervention group
Group type: COMPARATOR
Intervention: Low IL-6 cytokine production (<75th percentile)
Number of subjects: 50
Study 9817939 — intervention group
Group type: EXPERIMENTAL
Intervention: TNF-alpha cytokine production
Number of subjects: 50
Study 7658278 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine 5'-monophosphate bronchial challenge
Number of subjects: 54
Study 7658278 — intervention group
Group type: COMPARATOR
Intervention: Methacholine bronchial challenge
Number of subjects: 54
Study 2759456 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience-based educational intervention (interviewing volunteer nursing home residents)
Number of subjects: 0
Study 1011909 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital stretching of the anal canal (anal dilatation)
Number of subjects: 66
Study 1011909 — intervention group
Group type: COMPARATOR
Intervention: Modified lateral subcutaneous sphincterotomy
Number of subjects: 66
Study 11809090 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia
Number of subjects: 14
Study 31331757 — intervention group
Group type: EXPERIMENTAL
Intervention: IP cefepime monotherapy, 1g/d
Number of subjects: 144
Study 31331757 — intervention group
Group type: COMPARATOR
Intervention: IP combination of cefazolin and ceftazidime, 1g/d
Number of subjects: 144
Study 28926675 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher personal technology usage
Number of subjects: 0
Study 28926675 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher thwarted belongingness
Number of subjects: 0
Study 26511123 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-Incision Laparoscopic Surgery (SILS)
Number of subjects: 60
Study 26511123 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Surgery (LS)
Number of subjects: 60
Study 26511123 — intervention group
Group type: EXPERIMENTAL
Intervention: Precision Cutting Task
Number of subjects: 60
Study 26511123 — intervention group
Group type: EXPERIMENTAL
Intervention: Peg Transfer Task
Number of subjects: 60
Study 26511123 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender Comparison
Number of subjects: 60
Study 25449505 — intervention group
Group type: EXPERIMENTAL
Intervention: eGFR group-III (≤ 59 ml/min/1.73 m²)
Number of subjects: 149
Study 23016708 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride
Number of subjects: 70
Study 20442982 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigated TKA
Number of subjects: 80
Study 20442982 — intervention group
Group type: COMPARATOR
Intervention: Conventional TKA
Number of subjects: 80
Study 17398308 — intervention group
Group type: EXPERIMENTAL
Intervention: 1800 mg of eicosapentaenoic acid (EPA) daily with statin (EPA group; n=9326)
Number of subjects: 18645
Study 17398308 — intervention group
Group type: COMPARATOR
Intervention: Statin only (controls; n=9319)
Number of subjects: 18645
Study 17398308 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA treatment in patients with a history of coronary artery disease
Number of subjects: 18645
Study 17398308 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA treatment in patients with no history of coronary artery disease
Number of subjects: 18645
Study 15913007 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition 1: Memorized descriptions of how segments are arranged to form patterns
Number of subjects: 0
Study 15913007 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition 2: Memorized segments and mentally amalgamated them into patterns
Number of subjects: 0
Study 15913007 — intervention group
Group type: COMPARATOR
Intervention: Both conditions
Number of subjects: 0
Study 12612514 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersion technique
Number of subjects: 50
Study 12612514 — intervention group
Group type: COMPARATOR
Intervention: Air insufflation alone
Number of subjects: 50
Study 10475405 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitecapone (50 microM solution in Plegisol)
Number of subjects: 30
Study 10475405 — intervention group
Group type: COMPARATOR
Intervention: Crystalloid cardioplegia (Plegisol)
Number of subjects: 30
Study 8745384 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproic acid, 125 mg twice daily
Number of subjects: 1
Study 8745384 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 1
Study 1716979 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotinine-assisted smoking intervention programme (interpreted measurement of serum cotinine, self-help smoking cessation booklet, repeat serum cotinine measurement one month later)
Number of subjects: 2848
Study 1716979 — intervention group
Group type: COMPARATOR
Intervention: Usual anti-smoking advice provided by the antenatal care site
Number of subjects: 2848
Study 6181617 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic somatostatin
Number of subjects: 20
Study 6181617 — intervention group
Group type: COMPARATOR
Intervention: Control (no somatostatin)
Number of subjects: 20
Study 31424575 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited health literacy (LHL)
Number of subjects: 1400
Study 31424575 — intervention group
Group type: EXPERIMENTAL
Intervention: Spanish speakers
Number of subjects: 1400
Study 31424575 — intervention group
Group type: EXPERIMENTAL
Intervention: High school education or less
Number of subjects: 1400
Study 31424575 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonwhite race
Number of subjects: 1400
Study 31424575 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 1400
Study 31424575 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater social support
Number of subjects: 1400
Study 31424575 — intervention group
Group type: COMPARATOR
Intervention: Prior ACP experience
Number of subjects: 1400
Study 29508066 — intervention group
Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA)
Number of subjects: 40
Study 29508066 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (sham LIA)
Number of subjects: 40
Study 27592224 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive servoventilation
Number of subjects: 0
Study 27592224 — intervention group
Group type: COMPARATOR
Intervention: Optimum medical treatment for heart failure alone (Control group)
Number of subjects: 0
Study 25283504 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous recombinant urate oxidase (uricase) at doses of 0.1, 0.2, and 0.3 mg/kg; multiple doses of 0.2 mg·kg(‐1)·d(‐1) for 7 days
Number of subjects: 40
Study 25283504 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous recombinant urate oxidase (uricase)
Number of subjects: 40
Study 25283504 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 23007493 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial cooling garment (CS)
Number of subjects: 9
Study 23007493 — intervention group
Group type: COMPARATOR
Intervention: No cooling (NCS)
Number of subjects: 9
Study 21119098 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care program (5 individual counseling sessions by a pharmacist over 1 year)
Number of subjects: 899
Study 21119098 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 899
Study 21119098 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Pharmaceutical care and Usual care)
Number of subjects: 899
Study 17959976 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonthermosoftened ETTs
Number of subjects: 200
Study 17959976 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonthermosoftened ETTs obturated with an inflated esophageal stethoscope
Number of subjects: 200
Study 17959976 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermosoftened ETTs
Number of subjects: 200
Study 17959976 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermosoftened ETTs obturated with an inflated esophageal stethoscope
Number of subjects: 200
Study 15877788 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide 0.1 mg subcutaneously at the time of operation and 3x/d thereafter until post-operative day 7
Number of subjects: 40
Study 15877788 — intervention group
Group type: COMPARATOR
Intervention: Control group (no octreotide)
Number of subjects: 40
Study 12059898 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP (1 cmH2O above the pressure at the lower inflexion point, mean 14±3 cmH2O)
Number of subjects: 16
Study 12059898 — intervention group
Group type: COMPARATOR
Intervention: ZEEP (no PEEP)
Number of subjects: 16
Study 9477052 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular neostigmine (500 microg)
Number of subjects: 60
Study 9477052 — intervention group
Group type: COMPARATOR
Intervention: Control groups (intra-articular saline, s.c. neostigmine)
Number of subjects: 60
Study 9477052 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular neostigmine (125 microg and 250 microg)
Number of subjects: 60
Study 8583174 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraexaminer reliability for L1-L5 absolute rotation angle
Number of subjects: 3
Study 8583174 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraexaminer reliability for anterior/posterior thorax translation
Number of subjects: 3
Study 8583174 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraexaminer reliability for arcuate angle (AA)
Number of subjects: 3
Study 8583174 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraexaminer reliability for Ferguson's angle (FA)
Number of subjects: 3
Study 8583174 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraexaminer reliability for relative rotation angles
Number of subjects: 3
Study 8583174 — intervention group
Group type: EXPERIMENTAL
Intervention: Interexaminer reliability for the three examiners
Number of subjects: 3
Study 2795592 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip (IHG)
Number of subjects: 40
Study 2795592 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicycle ergometric exercise (BEE)
Number of subjects: 40
Study 2795592 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyramine infusion (TI)
Number of subjects: 40
Study 2795592 — intervention group
Group type: COMPARATOR
Intervention: Saline (control for TI)
Number of subjects: 40
Study 346293 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole
Number of subjects: 22
Study 346293 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim/sulfamethoxazole
Number of subjects: 22
Study 346293 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 346293 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitressin concentration test
Number of subjects: 22
Study 30531542 — intervention group
Group type: EXPERIMENTAL
Intervention: Nested Polymerase Chain Reaction (PCR)
Number of subjects: 30
Study 30531542 — intervention group
Group type: COMPARATOR
Intervention: Normal skin biopsies (Control)
Number of subjects: 30
Study 28806982 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm-guided blood glucose control (LOGIC-C, n=777)
Number of subjects: 1550
Study 26429559 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory training workshops (12 sessions, 90 minutes each, once a week)
Number of subjects: 230
Study 26429559 — intervention group
Group type: COMPARATOR
Intervention: Control group (not participating in memory training workshops)
Number of subjects: 230
Study 23890768 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed 500 mg/m² on day 1 plus erlotinib 150 mg daily on days 2-14
Number of subjects: 240
Study 23890768 — intervention group
Group type: COMPARATOR
Intervention: Erlotinib 150 mg daily
Number of subjects: 240
Study 23890768 — intervention group
Group type: COMPARATOR
Intervention: Pemetrexed 500 mg/m² on day 1
Number of subjects: 240
Study 21183106 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogel bandage
Number of subjects: 316
Study 21183106 — intervention group
Group type: COMPARATOR
Intervention: Corneal shield
Number of subjects: 316
Study 19372532 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (clinic-based, individually tailored counseling sessions)
Number of subjects: 1044
Study 19372532 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 1044
Study 17333123 — intervention group
Group type: COMPARATOR
Intervention: Manual physical therapy (Group 2)
Number of subjects: 30
Study 17333123 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-training program (Group 1)
Number of subjects: 30
Study 15144242 — intervention group
Group type: EXPERIMENTAL
Intervention: Early oral feeding without NG tube (Group B)
Number of subjects: 100
Study 15144242 — intervention group
Group type: COMPARATOR
Intervention: NG catheter and fasting until passage of flatus (Group A)
Number of subjects: 100
Study 15144242 — intervention group
Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 100
Study 12536650 — intervention group
Group type: EXPERIMENTAL
Intervention: Nylestriol (2 mg)
Number of subjects: 30
Study 12536650 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 10545723 — intervention group
Group type: EXPERIMENTAL
Intervention: Bionormalizer 9 g at bedtime and 3 h prior examination
Number of subjects: 22
Study 10545723 — intervention group
Group type: COMPARATOR
Intervention: Flavored sugar 9 g as placebo
Number of subjects: 22
Study 10545723 — intervention group
Group type: COMPARATOR
Intervention: Ethanol ingestion
Number of subjects: 22
Study 7589041 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine
Number of subjects: 10
Study 7589041 — intervention group
Group type: COMPARATOR
Intervention: D-glucose
Number of subjects: 10
Study 2328301 — intervention group
Group type: EXPERIMENTAL
Intervention: Austyn (sustained-release theophylline capsule) with food
Number of subjects: 18
Study 2328301 — intervention group
Group type: EXPERIMENTAL
Intervention: Austyn (sustained-release theophylline capsule) fasting
Number of subjects: 18
Study 2328301 — intervention group
Group type: COMPARATOR
Intervention: Elixophyllin elixir (reference product) fasting
Number of subjects: 18
Study 2328301 — intervention group
Group type: EXPERIMENTAL
Intervention: Austyn capsules (multiple dosing)
Number of subjects: 18
Study 2328301 — intervention group
Group type: COMPARATOR
Intervention: Theo-Dur (sustained-release tablet)
Number of subjects: 18
Study 2328301 — intervention group
Group type: EXPERIMENTAL
Intervention: Austyn (sustained-release capsule)
Number of subjects: 18
Study 7211858 — intervention group
Group type: EXPERIMENTAL
Intervention: Pfi‐Lithium (300 mg)
Number of subjects: 18
Study 7211858 — intervention group
Group type: COMPARATOR
Intervention: Eskalith (300 mg)
Number of subjects: 18
Study 31788006 — intervention group
Group type: COMPARATOR
Intervention: Wright® nebulizer
Number of subjects: 18
Study 31788006 — intervention group
Group type: EXPERIMENTAL
Intervention: Solo® nebulizer
Number of subjects: 18
Study 31788006 — intervention group
Group type: COMPARATOR
Intervention: Wright® methacholine
Number of subjects: 18
Study 31788006 — intervention group
Group type: EXPERIMENTAL
Intervention: Solo® methacholine
Number of subjects: 18
Study 27906684 — intervention group
Group type: EXPERIMENTAL
Intervention: PF-03084014 100 mg twice daily / docetaxel 75 mg/m2
Number of subjects: 29
Study 26115087 — intervention group
Group type: EXPERIMENTAL
Intervention: High-energy-dense preload (94 kcal/100 g)
Number of subjects: 24
Study 26115087 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy-dense preload (53 kcal/100 g)
Number of subjects: 24
Study 26115087 — intervention group
Group type: COMPARATOR
Intervention: No preload
Number of subjects: 24